Legend Biotech (LEGN) Other Operating Expenses (2020 - 2026)
Legend Biotech's (LEGN) quarterly Other Operating Expenses came in at -$5.1 million in Q1 2026, up 90.64% YoY from -$2.7 million in Q1 2025, and up 90.64% on a QoQ basis from -$54.5 million in Q1 2025.
Legend Biotech (LEGN) Other Operating Expenses (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 5 years of Other Operating Expenses data on file, last reported at -$5.1 million in Q1 2026.
- Quarterly Other Operating Expenses rose 90.64% year-over-year to -$5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.1 million (up 90.64% YoY) and the FY2024 annual result came in at -$4423.0, changed N/A from the prior year.
- Other Operating Expenses advanced to -$5.1 million in Q1 2026, from -$54.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$4423.0 in Q4 2024 to a low of -$54.5 million in Q1 2025.
- A 3-year average of -$19.9 million and a median of -$5.1 million in 2026 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 90.64% in 2026, down 90.64% in 2026.
- Tracing LEGN's Other Operating Expenses over 3 years: stood at -$4423.0 in 2024, then slumped by 1232095.34% to -$54.5 million in 2025, then soared by 90.64% to -$5.1 million in 2026.
- The last three Other Operating Expenses figures came in at -$5.1 million (Q1 2026), -$54.5 million (Q1 2025), and -$4423.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.00 Mn |
| Mar 31, 2026 | -5.10 Mn |
| Mar 31, 2025 | -54.50 Mn |
| Dec 31, 2024 | -4,423.00 |
| Sep 30, 2021 | 40,000.00 |
| Sep 30, 2020 | 10,000.00 |